News | Advanced Visualization | February 15, 2018

NIH Issues $2.2 Million Grant for Augmented Reality Cardiac Hologram Research

Technology allows real-time viewing, measurement and manipulation of patient anatomy in a holographic display for procedural guidance

NIH Issues $2.2 Million Grant for Augmented Reality Cardiac Hologram Research

February 15, 2018 — The National Institutes of Health (NIH) awarded a $2.2 million research grant to healthcare technology company SentiAR Inc. to advance its work to design augmented reality (AR) software to improve visualization in cardiac surgeries and other interventional procedures. The grant was awarded following peer review by a panel of cardiologists, engineers and other experts.

SentiAR will receive $2.2 million of non-dilutive milestone installments to advance its platform. Using the SentiAR technology, through the Microsoft heads-up display, physicians can view, measure and manipulate real-time holographic images of the patient’s heart during medical procedures – while still being able to clearly see the operating room environment – giving physicians complete, real-time, visual control of both the virtual and real worlds. Using real-time navigation data feeds rather than magnetic resonance imaging (MRI) or computed tomography (CT), the SentiAR intraprocedural solution provides clinicians with patient-specific anatomy in a holographic display, including catheter movement, in full control of the proceduralist. The software is aimed at reducing operating time and radiation exposure to clinicians, and potentially improving outcomes for patients. In-human engineering testing began in summer 2017.

“Our goal is to provide physicians who perform cardiac ablation procedures with a patient-specific hologram of the heart and the instruments that they are using inside of it,” said Jennifer Silva, M.D., SentiAR chief medical officer. “By improving the visualization of this information and empowering the physician with direct control of the model, we will make these procedures both simpler and safer. ”

The grant-funded project period is now underway, supervised by Principal Investigator Walter Blume. The company is targeting U.S. Food and Drug Administration (FDA) submission later in 2018.

For more information: www.sentiar.com

Related Augmented Reality Content

VIDEO: ITN Introduces Augmented Reality

VIDEO: Editor's Choice of the Most Innovative New Imaging Technology at RSNA 2017

Editor's Choice of Most Innovative Technology at HIMSS 2017

Related Content

TeraRecon Unveils iNtuition AI Data Extractor
News | Advanced Visualization | July 03, 2019
Artificial Intelligence (AI) and advanced visualization company TeraRecon announced its new iNtuition AI Data Extractor...
A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model.

A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model. Photo courtesy of Nicole Wake, Ph.D.

Feature | Advanced Visualization | July 02, 2019 | By Jeff Zagoudis
Three-dimensional (3-D) printing and...

Image courtesy of Philips Healthcare

Feature | Molecular Imaging | July 01, 2019 | By Sharvari Rale
Diagnostic procedures have always been a cornerstone of early prognosis and patient triaging.
TeraRecon Receives FDA Clearance for Northstar AI Results Explorer
Technology | Artificial Intelligence | June 20, 2019
Advanced visualization and artificial intelligence (AI) technology provider TeraRecon has successfully completed a U.S...
Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite
Technology | Advanced Visualization | June 13, 2019
Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug...
Medivis SurgicalAR Gets FDA Clearance
Technology | Virtual and Augmented Reality | June 10, 2019
Medivis announced that its augmented reality (AR) technology platform for surgical applications, SurgicalAR, has...
Ann Arbor Startup Launches Augmented Reality MRI Simulator
Technology | Virtual and Augmented Reality | June 04, 2019
SpellBound, an Ann Arbor startup specializing in augmented reality (AR) tools for children in hospitals, has officially...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Advanced Visualization | May 16, 2019
This is an example of how virtual reality is being used in neuro-radiology to better evaluate patients using advanced